期刊文献+

亚临床甲状腺功能减退症的筛查 被引量:3

Screening for Subclin ical Hypothyroidism.
下载PDF
导出
摘要 目的:观察本科甲状腺疾病患者中亚临床甲状腺功能减退症(甲减)的发病情况,分析其病因及临床特点。方法:选取2002年9~12月本科甲状腺疾病患者血清2009份,采用化学发光免疫分析法检测促甲状腺激素(TSH)、游离三碘甲状腺原氨酸(FT3)、游离四碘甲状腺原氨酸(FT4)。亚临床甲减以TSH>4.5mU/L且FT3、FT4在正常值范围为诊断标准。结果:①本科甲状腺疾病患者中检出亚临床甲减123例,检出率为6.12%,其中男性5.73%,女性6.26%;②病因:甲状腺炎患者占53.7%,医源性甲减者占46.3%;③临床特点:有不适主诉者占66.7%,有血脂异常或传导阻滞或心包积液者占30.9%,其中≥55岁占71.1%。结论:亚临床甲减是一组异质性疾病,甲状腺炎是最常见的病因,医源性因素次之,临床表现类似甲减,可有心血管系统、神经精神系统及脂质代谢的异常。 Objective:To study the occurence of subclinical hypothyroidism among patie nt s with thyroid diseases in our depart-ment of endocrinology,and evaluate its et iology and clinical feature.Methods:From Sep2002through Dec2002,thyroid stimulat ing hormone(TSH)and free thyroxine(FT 3 and FT 4 )were detected in2009serum specimens by chemilumino-im-munoassay.Subclinic al hypothyroidism was diagnosed by an elevated level of TSH(>4.5mU/L)with normal range of FT 3 and FT 4 concentration.Results:①The occurence of subclinical hypothyrodism was6.12%i n patients with thyroid dis-eases,and was5.73%and6.26%among males and females,r espectively.②Etiological analysis showed that thyroiditis and iatrogenic hypoth yrodism were53.7%and46.3%,respectively.③There were66.7%patients complained of d iscom-forts(66.7%),dyslipidemia,heart block or pericardiac effusion were30.9%an d71.1%of patients were older than55years.Conclusions:Subclinical hypothyroidism is a heterogeneous disorder.Thyroiditis and iatrogenic factors are its the most common causes.Its clinical feature is similar to hypothyroidism,including disord ers of cardiovascular,mental and nervous system,and lipids metabolism.
出处 《诊断学理论与实践》 2003年第2期117-118,共2页 Journal of Diagnostics Concepts & Practice
关键词 亚临床甲状腺功能减退症 筛查 促甲状腺激素 化学发光免疫分析法 Subclinical hypothyroidism Thyroid stimulating hormone Chemilumino-immunoassay
  • 相关文献

参考文献4

  • 1刘超,蒋须勤.亚临床甲减[J].江苏医药,2000,26(9):712-713. 被引量:11
  • 2[2]Ross DS. Serum thyroid-stimulating hormone measurement for assessment of thyroid function and disease [J].Endocrinol Metab Clin Nor Amer,2001,30(2):245-264.
  • 3[3]Fatourechi V. Subclinical thyroid disease [J]. Mayo Clin Proc, 2001, 76:413-417.
  • 4[4]Vanderpump MPJ, Tunbridge WMG. Epidemiology and prevention of clinical and subclinical hypothyroidism [J].Thytoid,2002, 12(10):839-847.

二级参考文献4

共引文献10

同被引文献19

  • 1王青平,贾清珍.亚临床甲状腺疾病研究进展[J].中国地方病防治,2004,19(3):159-161. 被引量:3
  • 2彭兰,陈孝进,袁选波.磁分离酶联免疫技术和放射免疫法测定甲状腺功能指标的比较[J].微循环学杂志,2005,15(4):129-130. 被引量:2
  • 3钱春花,唐伟,刘超.环境内分泌干扰物与甲状腺疾病关系的研究进展[J].国外医学(卫生学分册),2006,33(2):106-109. 被引量:10
  • 4Baloch Z, Carayon P, Conte-Devolx B, et al. Laboratory medicine practice guidelines:laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid, 2003,13:123-126.
  • 5Bensenor I. Screening for thyroid disorders in asymptomatic adults from Brazilian populations. Sao Paulo Med J, 2002,120 : 146-151.
  • 6Sawin CT, Castelli WP, Hershman JM, et al. The aging thyroid. Thyroid deficiency in the Framingham study. Arch Intern Med, 1985, 145 : 1386-1388,
  • 7Tubridge WM, Evered DC, Hall R, et al. The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol ( Oxf), 1977,7:481-493.
  • 8Canaris GJ, Manowitz NR, Mayor G. The Colorado thyroid disease prevalence study. Arch Intern Med, 2000,160:526-534.
  • 9Heinisch M, Kumnig G, Asbock D, et al. Goiter prevalence and urinary iodide excretion in a formerly iodine-deficient region after introduction of statutory iodization of common salt. Thyroid, 2002,12 : 809-814.
  • 10Diez JJ, Iglesias P. Spontaneous subclinical hypothyroidism in patients older than 55 years : an analysis of natural course and risk factors for the development of overt thyroid failure. J Clin Endocrinol Metab, 2004, 89:4890-4897.

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部